A share price of Dexcom Inc [DXCM] is currently trading at $64.85, up 0.62%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The DXCM shares have gain 5.12% over the last week, with a monthly amount glided 7.31%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Dexcom Inc [NASDAQ: DXCM] stock has seen the most recent analyst activity on December 02, 2025, when Morgan Stanley upgraded its rating to a Overweight but kept the price target unchanged to $75 for it. Previously, Evercore ISI started tracking the stock with In-line rating on November 25, 2025, and set its price target to $68. Oppenheimer downgraded its rating to a Perform. Argus initiated its recommendation with a Buy and recommended $100 as its price target on August 21, 2025. Truist started tracking with a Buy rating for this stock on June 16, 2025, and assigned it a price target of $102. In a note dated May 30, 2025, Goldman initiated an Buy rating and provided a target price of $104 on this stock.
Dexcom Inc experienced fluctuations in its stock price throughout the past year between $54.11 and $93.25. Currently, Wall Street analysts expect the stock to reach $85.22 within the next 12 months. Dexcom Inc [NASDAQ: DXCM] shares were valued at $64.85 at the most recent close of the market. An investor can expect a potential return of 31.41% based on the average DXCM price forecast.
Analyzing the DXCM fundamentals
Trailing Twelve Months sales for Dexcom Inc [NASDAQ:DXCM] were 4.52B which represents 21.64% growth. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.21%, and Net Profit Margin reading is 0.16%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is 0.3 and Total Capital is 0.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.92.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 64.24 points at the first support level, and at 63.63 for the second support level. However, for the 1st resistance point, the stock is sitting at 65.31, and for the 2nd resistance point, it is at 65.77.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Dexcom Inc [NASDAQ:DXCM] is 1.56. As well, the Quick Ratio is 1.38, while the Cash Ratio is 0.55. Considering the valuation of this stock, the price to sales ratio is 5.60, the price to book ratio is 9.28 and price to earnings (TTM) ratio is 36.09.
Transactions by insiders
Recent insider trading involved Collins Richard Alexander, Director, that happened on Nov 14 ’25 when 2906.0 shares were sold. Director, Collins Richard Alexander completed a deal on Nov 14 ’25 to buy 2906.0 shares. Meanwhile, Director Heller Bridgette P sold 1012.0 shares on Nov 12 ’25.
